The studies indicate that OTREXUP is safe, easy and comfortable for RA patients to self-administer precise subcutaneous doses of MTX with improved systemic availability compared to oral doses.
METHODS: Human subjects ingested either 150 mg or 300 mg quercetin-4'-O-beta-Dglucoside supplement to determine the systemic availability of quercetin.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.